Skip to main content

Table 1 Patient characteristics at the time of initial diagnosis

From: The utility of 18 F-FDG PET/CT for suspected recurrent breast cancer: impact and prognostic stratification

Characteristics

Number of patients (%)

 

(sample size = 63)

Localisation

 

 Right

30 (48)

 Left

29 (46)

 Bilateral

4 (6)

Histology

 

 Ductal

42 (67)

 Lobular

11 (17)

 Other

7 (12)

 Unknown

3 (5)

Histological grade

 

 1 and 2

28 (44)

 3

25 (40)

 Unknown

10 (16)

Lymphovascular invasion

 

 +

22 (35)

 -

23 (36)

 Unknown

18 (29)

Estrogen receptor status

 

 +

34 (54)

 -

20 (32)

 Unknown

9 (14)

Progesterone receptor status

 

 +

25 (40)

 -

28 (44)

 Unknown

10 (16)

HER2 status

 

 +

9 (14)

 -

29 (46)

 Unknown

25 (40)

T stage

 

 1

29 (46)

 2

17 (27)

 3

10 (16)

 4

3 (5)

 X

4 (6)

N status

 

 +

29 (46)

 -

31 (49)

 X

3 (5)

  1. HER-2 = Human Epidermal Growth Factor Receptor-2.